The story has been updated with comments from a conference call held earlier today.

NEW YORK (GenomeWeb News) – Qiagen reported on Sunday a 5 percent increase in third-quarter revenues year over year, paced by the company's consumables sales.

Revenues in the quarter totaled $304.3 million, up from $288.9 million a year ago and beating the consensus Wall Street estimate of $303.8 million. At constant exchange rates (CER), revenues rose 10 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.